We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Implantable Lens Treats Presbyopia

By HospiMedica staff writers
Posted on 09 Feb 2006
An implantable intraocular lens features a hinged design that allows the lens to move forward as the eye attempts to focus on nearby objects, restoring some accommodative function in presbyopic patients.

Presbyopia is a condition in which the normal changes in the shape of the lens that occur when looking from a far-away object to a near one (or vice-versa) are limited. More...
Normally, the iris causes the lens to change shape as one looks at objects at varying distances. This phenomenon, called accommodation, allows the eye to focus at different lengths. When accommodation is impaired, the eye is unable to adjust sufficiently to nearby objects. As a result, people with presbyopia may be seen holding reading material at arm's length in order to discern what is written.

The Tek-Clear, an accommodative intraocular lens made by Tekia (Irvine, Ca, USA) is a 5-mm implantable accommodative intraocular lens (IOL) that features a 360º full bag haptic square-edge design and an antiglare shield. Applications include its use in cataract surgery to restore near vision while correcting for other visual disorders such as hyperopia; and to restore near and intermediate vision in pre-cataract patients, thereby eliminating their need for glasses or contact lenses.

The IOL is implanted after the lens is surgically removed. It uses the eye's ocular structures to shift the lens forward and enable close-up vision, and then shifts back to the resting position to allow visualization of distant objects. The lens has received the CE Mark.




Related Links:
Tekia

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.